Start / PharmaTalkRadio / What cmos must know about how patient engagement supports the entire biotech

PharmaTalkRadio

What CMOs Must Know About How Patient Engagement Supports the Entire Biotech

32 min • 3 oktober 2022

This session recorded at CMO Summit 2022 gives CMOs an update on current views on patient-centric medicine development, what it really means and the benefits for both the patient and trial. More specifically: Achieving timely recruitment by better selecting sites and writing good protocolsWorking with patient advocacy groups to integrate patient voice in trial design and drive better enrollmentAchieving enrollment when there is so much competition for patients Speakers: Jodie Gillon, MPH, SVP Corporate Affairs & Patient Advocacy, PeptilogicsBarry Ticho, MD, PhD, CMO, Stoke TherapeuticsRolf Benirschke, Patient Advocate & Former NFL Player, Legacy Health StrategiesRoger Waltzman, MD, MBA, CMO, Molecular Templates

Senaste avsnitt

De-Risking Clinical Operations by Taking a Scaffolding Approach to Outsourcing

12 augusti | 28 min

Balancing Between Concentration and Volume when Developing Patient-Centric Biologics

12 augusti | 28 min

Directors' Talk DPHARM 2025 - AI Sessions; Part III

25 juli | 6 min

Innovations in Manufacturing to Make CAR-T More Accessible and Affordable

25 juli | 20 min

Achieving Oral Delivery of Peptides through Formulation and Molecule Design Approaches

25 juli | 29 min

Podcastbild

00:00 -00:00

Podcastbild

00:00 -00:00